Pre-exposure prophylaxis for HIV prevention preferences among young adult African American men who have sex with men.

by Rupa R Patel, John S Crane, Julia López, Philip A Chan, Albert Y Liu, Rubabin Tooba, Aimee S James
Published 2018-01-01

Comparing pharmacologic measures of tenofovir exposure in a U.S. pre-exposure prophylaxis randomized trial.

by Sanjiv M Baxi, Eric Vittinghoff, Peter Bacchetti, Yong Huang, Kata Chillag, Ryan Wiegand, Peter L Anderson, Robert Grant, Ruth M Greenblatt, Susan Buchbinder, Monica Gandhi, Albert Y Liu
Published 2018-01-01

Daily oral emtricitabine/tenofovir preexposure prophylaxis and herpes simplex virus type 2 among men who have sex with men.

by Julia L Marcus, David V Glidden, Vanessa McMahan, Javier R Lama, Kenneth H Mayer, Albert Y Liu, Orlando Montoya-Herrera, Martin Casapia, Brenda Hoagland, Robert M Grant
Published 2014-01-01

Strong relationship between oral dose and tenofovir hair levels in a randomized trial: hair as a potential adherence measure for pre-exposure prophylaxis (PrEP).

by Albert Y Liu, Qiyun Yang, Yong Huang, Peter Bacchetti, Peter L Anderson, Chengshi Jin, Kathy Goggin, Kristefer Stojanovski, Robert Grant, Susan P Buchbinder, Ruth M Greenblatt, Monica Gandhi
Published 2014-01-01

Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San Francisco.

by Albert Y Liu, Eric Vittinghoff, Deborah E Sellmeyer, Risha Irvin, Kathleen Mulligan, Kenneth Mayer, Melanie Thompson, Robert Grant, Sonal Pathak, Brandon O'Hara, Roman Gvetadze, Kata Chillag, Lisa Grohskopf, Susan P Buchbinder
Published 2011-01-01

No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis.

by Julia L Marcus, David V Glidden, Kenneth H Mayer, Albert Y Liu, Susan P Buchbinder, K Rivet Amico, Vanessa McMahan, Esper Georges Kallas, Orlando Montoya-Herrera, Jose Pilotto, Robert M Grant
Published 2013-01-01

Performance of HIV pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: Results from the PrEP Brasil Study.

by Luana M S Marins, Thiago S Torres, Iuri da C Leite, Ronaldo I Moreira, Paula M Luz, Brenda Hoagland, Esper G Kallas, José Valdez Madruga, Albert Y Liu, Peter L Anderson, Beatriz Grinsztejn, Valdilea G Veloso
Published 2019-01-01

Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.

by Raphael J Landovitz, Sue Li, Beatriz Grinsztejn, Halima Dawood, Albert Y Liu, Manya Magnus, Mina C Hosseinipour, Ravindre Panchia, Leslie Cottle, Gordon Chau, Paul Richardson, Mark A Marzinke, Craig W Hendrix, Susan H Eshleman, Yinfeng Zhang, Elizabeth Tolley, Jeremy Sugarman, Ryan Kofron, Adeola Adeyeye, David Burns, Alex R Rinehart, David Margolis, William R Spreen, Myron S Cohen, Marybeth McCauley, Joseph J Eron
Published 2018-11-01

HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.

by Timothy J Henrich, Hiroyu Hatano, Oliver Bacon, Louise E Hogan, Rachel Rutishauser, Alison Hill, Mary F Kearney, Elizabeth M Anderson, Susan P Buchbinder, Stephanie E Cohen, Mohamed Abdel-Mohsen, Christopher W Pohlmeyer, Remi Fromentin, Rebecca Hoh, Albert Y Liu, Joseph M McCune, Jonathan Spindler, Kelly Metcalf-Pate, Kristen S Hobbs, Cassandra Thanh, Erica A Gibson, Daniel R Kuritzkes, Robert F Siliciano, Richard W Price, Douglas D Richman, Nicolas Chomont, Janet D Siliciano, John W Mellors, Steven A Yukl, Joel N Blankson, Teri Liegler, Steven G Deeks
Published 2017-11-01